IP Library › Granted Patent US 12,193,956
Granted Patent B2
US 12,193,956 · App. 17/066,009 · Granted Jan 14, 2025

Urological chitosan stent and delivery system

Inventors: Moritz Koroschetz (Boston, MA); Seiichi Ito (Lexington, MA)
Assignee: Gyrus ACMI, Inc.
A61F2/958A61F2002/047A61F2210/0004A61F2210/0076A61F2250/0039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,193,956
App. No.
17/066,009
Granted
Jan 14, 2025
Kind
B2
Abstract

An apparatus includes a first layer, wherein the first layer comprises a scaffold structure forming an inner lumen along a length of the scaffold structure, and wherein the first layer comprises a bioresorbable material; a second layer on the first layer, wherein the second layer comprises a bioresorbable material configured to expand, wherein the second layer is positioned on the first layer such that ends of the first layer extend beyond ends of the second layer; and an expandable balloon located within a distal end of the inner lumen of the first layer.

Claims (35)

1. A stent apparatus for insertion into a prostatic urethra of a patient, comprising:

a first layer, wherein the first layer comprises a scaffold structure forming an inner lumen along a length of the scaffold structure, and wherein the first layer comprises a bioresorbable material;

a second layer on the first layer, wherein the second layer comprises a bioresorbable material configured to expand, wherein the second layer is positioned on the first layer such that ends of the first layer extend beyond ends of the second layer; and

an expandable balloon located within a distal end of the inner lumen of the first layer, the balloon configured to expand such that at least a portion of the balloon extends distally beyond the distal end of the inner lumen of the first layer for engagement with surrounding tissue;

wherein the second layer is configured to expand and press against an inner surface of the prostatic urethra when the second layer is exposed to a liquid draining through the prostatic urethra.

2. The apparatus of claim 1 , wherein the balloon is expandable through the inner lumen, collapsible through the inner lumen, and retractable from a distal end of the first layer through the inner lumen.

3. The apparatus of claim 1 , further comprising an applicator serially coupled to a proximal end of the apparatus, the applicator comprising a multi-lumen tube having at least an irrigation lumen through which a fluid may be delivered to a patient and a drain lumen through which the fluid may be removed from the patient.

4. The apparatus of claim 3 , wherein the applicator is serially coupled to the proximal end of the apparatus using a compression covering on a distal end of the applicator and the proximal end of the apparatus.

5. The apparatus of claim 4 , wherein the compression covering comprises a sheath having a first sheath layer coupling the distal end of the applicator to the proximal end of the applicator.

6. The apparatus of claim 5 , wherein the sheath further comprises a second sheath layer on the first sheath layer and covering from a distal end of the second layer to the proximal end of the applicator such that upon removal of the second sheath layer the second layer may be exposed to a liquid.

7. The apparatus of claim 6 , wherein the sheath further comprises a third sheath layer on the second sheath layer and covering from a distal end of the first layer to the proximal end of the applicator.

8. The apparatus of claim 1 , wherein at least one of a distal end of the first layer or a proximal end of the first layer is configured to expand into a funnel shape.

9. The apparatus of claim 1 , wherein the bioresorbable material of the second layer is chitosan.

10. A stent apparatus for insertion into a prostatic urethra of a patient, comprising:

a scaffold structure forming an inner lumen along a length thereof, the scaffold structure being substantially tubular in shape and expandable in radial directions from an axis extending longitudinally through the tubular shape of the scaffold structure,

an expandable layer on the scaffold structure and covering a portion of the scaffold structure along a length thereof such that a distal end of the scaffold structure extends beyond a distal end of the expandable layer and a proximal end of the scaffold structure extends beyond a proximal end of the expandable layer, wherein a material of the second layer is configured to expand, and

an expandable balloon located within the distal end of the scaffold structure, the balloon configured to expand such that at least a portion of the balloon extends distally beyond the distal end of the scaffold structure for engagement with surrounding tissue,

wherein the expandable layer is configured to expand and press against an inner surface of the prostatic urethra when the expandable layer is exposed to a liquid draining through the prostatic urethra.

11. The apparatus of claim 10 , wherein the balloon is accessible through the inner lumen.

12. The apparatus of claim 11 , wherein the balloon is expandable through the inner lumen by injection of a liquid or a gas.

13. The apparatus of claim 11 , wherein the balloon is expandable through the inner lumen and collapsible and retractable through the inner lumen.

14. The apparatus of claim 10 , further comprising an applicator comprising,

a multi-lumen tube having at least an irrigation lumen through which a fluid may be delivered through the apparatus and to a patient and a drain lumen through which the fluid may be removed through the apparatus and from the patient, and

a compression covering serially coupling the multi-lumen tube to the proximal end of the apparatus.

15. The apparatus of claim 14 , wherein the compression covering comprises a first sheath layer coupling a proximal end of the scaffold structure to the applicator, a second sheath layer covering the expandable layer, and a third sheath layer covering from the distal end of the scaffold structure to the multi-lumen tube.

16. The apparatus of claim 10 , wherein a material of the scaffold structure and the material of the expandable layer each comprises a bioresorbable material.

17. The apparatus of claim 16 , wherein the bioresorbable material of at least the expandable layer comprises chitosan.

18. A method, comprising:

inserting an apparatus into a prostatic urethra of a patient, wherein the apparatus comprises a stent comprising a first layer comprising a scaffold structure of a bioresorbable material forming an inner lumen along a length of the scaffold structure, a second layer on the first layer, the second layer comprising a bioresorbable material configured to expand and being positioned on the first layer such that ends of the first layer extend beyond ends of the second layer, and an expandable balloon located within a distal end of the inner lumen of the first layer;

expanding the balloon to position the stent in the prostatic urethra;

expanding the second layer to cause the second layer to press against an inner surface of the prostatic urethra, wherein expanding the second layer comprises exposing the second layer to a liquid draining through the prostatic urethra; and

collapsing the balloon and retracting the balloon through the inner lumen.

19. The method of claim 18 , wherein expanding the balloon comprises injecting the balloon with a liquid or a gas.

20. The method of claim 18 , further comprising serially coupling an applicator to a proximal end of the stent.

21. The method of claim 20 , wherein exposing the second layer to the liquid draining through the prostatic urethra comprises removing a sheath layer at least partially serially coupling the applicator to the proximal end of the stent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2020
From: KOROSCHETZ, MORITZ; ITO, SEIICHI
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 054336/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2020
From: GYRUS ACMI, INC D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
To: OLYMPUS CORPORATION
Reel/Frame 054336/0672 →
Continuity (2)
Provisional Application 62912691 · Oct 9, 2019
Related Publication 20210106730A1 · Apr 15, 2021
References Cited (54)
US 9510959B2 · Shoham · 2016 [cited by examiner]
US 9517122B2 · Firstenberg · 2016 [cited by examiner]
US 10064626B2 · Celermajer · 2018 [cited by examiner]
US 10828184B1 · Schwartz · 2020 [cited by examiner]
US 11357651B2 · Venkatraman · 2022 [cited by examiner]
US 20010018585A1 · McGovern · 2001 [cited by examiner]
US 20020007206A1 · Bui · 2002 [cited by examiner]
US 20020082556A1 · Cioanta · 2002 [cited by examiner]
US 20020165521A1 · Cioanta · 2002 [cited by examiner]
US 20020173818A1 · Reever · 2002 [cited by examiner]
US 20030153899A1 · Eshel · 2003 [cited by examiner]
US 20030199993A1 · Gellman · 2003 [cited by examiner]
US 20040059389A1 · Chornenky · 2004 [cited by examiner]
US 20040172112A1 · Cioanta · 2004 [cited by examiner]
US 20040193283A1 · Rioux · 2004 [cited by examiner]
US 20040230188A1 · Cioanta · 2004 [cited by examiner]
US 20040230316A1 · Cioanta · 2004 [cited by examiner]
US 20060009832A1 · Fisher · 2006 [cited by examiner]
US 20060095124A1 · Benz · 2006 [cited by examiner]
US 20070255394A1 · Ryan · 2007 [cited by examiner]
US 20080015671A1 · Bonhoeffer · 2008 [cited by examiner]
US 20090018533A1 · Perkins · 2009 [cited by examiner]
US 20090177288A1 · Wallsten · 2009 [cited by examiner]
US 20100030263A1 · Cheng · 2010 [cited by examiner]
US 20100137978A1 · Atanasoska · 2010 [cited by examiner]
US 20100145325A1 · Hoey · 2010 [cited by examiner]
US 20100298948A1 · Hoey · 2010 [cited by examiner]
US 20120089218A1 · Dardi · 2012 [cited by examiner]
US 20140316509A1 · Corrigan, Jr. · 2014 [cited by applicant]
US 20180092732A1 · Kringle · 2018 [cited by examiner]
US 20180344991A1 · Cerchiari et al. · 2018 [cited by applicant]
US 20210220178A1 · Avior · 2021 [cited by examiner]
CN 104042376 · 2014 [cited by applicant]
CN 107334562 · 2017 [cited by applicant]
CN 112641544 · 2024 [cited by applicant]
JP 2005511199A · 2005 [cited by applicant]
JP 2013223663A · 2013 [cited by applicant]
JP 7036518B2 · 2022 [cited by applicant]
WO 03049643 · 2003 [cited by applicant]
WO WO2012011261A1 · 2012 [cited by applicant]
WO WO2017161331A1 · 2017 [cited by applicant]
WO 2019142077 · 2019 [cited by applicant]
“Chinese Application Serial No. 202010788273.2, Office Action mailed Oct. 10, 2023”, W/O English Translation, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 202010788273.2, Response filed Feb. 2, 2024 to Office Action mailed Oct. 10, 2023”, w english claims, 16 pgs. [cited by applicant]
“European Application Serial No. 20197288.2, Extended European Search Report mailed Mar. 9, 2021”, 4 pgs. [cited by applicant]
“European Application Serial No. 20197288.2, Communication Pursuant to Article 94(3) EPC mailed Mar. 26, 2021”, 6 pgs. [cited by applicant]
“Chinese Application Serial No. 202010788273.2, Voluntary Amendment filed Apr. 21, 2021”, with English translation of claims, 14 pgs. [cited by applicant]
“European Application Serial No. 20197288.2, Response filed Jul. 23, 2021 to Communication Pursuant to Article 94(3) EPC mailed Mar. 26, 2021”, 5 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-151925, Notification of Reasons for Refusal mailed Jul. 13, 2021”, w/ English Translation, 12 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-151925, Response filed Sep. 13, 2021 to Notification of Reasons for Refusal mailed Jul. 13, 2021”, with English translation of claims, 10 pgs. [cited by applicant]
“Chinese Application Serial No. 202010788273.2, Office Action mailed Apr. 3, 2024”, w/ English Translation, 14 pgs. [cited by applicant]
“Chinese Application Serial No. 202010788273.2, Response filed May 30, 2024 to Office Action mailed Apr. 3, 2024”, w/ current English claims, 15 pgs. [cited by applicant]
“European Application Serial No. 20197288.2, Communication Pursuant to Article 94(3) EPC mailed May 2, 2024”, 6 pgs. [cited by applicant]
“European Application Serial No. 20197288.2, Response filed Aug. 27, 2024 to Communication Pursuant to Article 94(3) EPC mailed May 2, 2024”, 9 pgs. [cited by applicant]
Cited By (1)
US 12,678,308